RightBio Metrics
Private Company
Total funding raised: $4.5M
Overview
RightBio Metrics is a private diagnostics company addressing a critical patient safety issue: the dangerous misplacement of NG/OG tubes. Its core innovation is the RightSpotpH® Indicator, a closed-system device that offers immediate, clear pH readings to confirm gastric placement, positioning itself as a superior alternative to unreliable auscultation (the 'whoosh test') and traditional pH paper. The company is commercial-stage, FDA-cleared, and CLIA-waived, targeting widespread adoption in hospitals to reduce X-ray reliance, lower costs, and prevent patient harm, including aspiration pneumonia and death.
Technology Platform
Closed-system, in-line pH indicator device for immediate visual verification of nasogastric/orogastric tube placement. Designed for clarity, contamination prevention, and workflow integration.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Primary competition is the current standard of care: unreliable auscultation and traditional pH paper strips. RightSpotpH® competes by offering greater accuracy, speed, and safety (closed system) versus paper, and by providing an objective, evidence-based alternative to the discredited auscultation method. Potential for new entrants with alternative verification technologies exists.